BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29939098)

  • 1. Biomarker imprecision in precision medicine.
    Pritzker K
    Expert Rev Mol Diagn; 2018 Aug; 18(8):685-687. PubMed ID: 29939098
    [No Abstract]   [Full Text] [Related]  

  • 2. Measure for Measure: Biomarker standards and transparency.
    FitzGerald GA
    Sci Transl Med; 2016 Jun; 8(343):343fs10. PubMed ID: 27306662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
    Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
    Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
    [No Abstract]   [Full Text] [Related]  

  • 5. Prioritizing personalized medicine.
    Shomron N
    Genet Res (Camb); 2014 Jul; 96():e007. PubMed ID: 25579247
    [No Abstract]   [Full Text] [Related]  

  • 6. Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.
    Browman GP
    J Clin Oncol; 2012 Dec; 30(34):4188-91. PubMed ID: 23071250
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma.
    Zhong L; Liu Y; Wang K; He Z; Gong Z; Zhao Z; Yang Y; Gao X; Li F; Wu H; Zhang S; Chen L
    BMC Cancer; 2018 Sep; 18(1):911. PubMed ID: 30241505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
    Umelo IA; Costanza B; Castronovo V
    Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care.
    Schneider D; Bianchini G; Horgan D; Michiels S; Witjes W; Hills R; Plun-Favreau J; Brand A; Lawler M;
    Public Health Genomics; 2015; 18(6):349-58. PubMed ID: 26571110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized/Precision Medicine/Personalised Healthcare: the art of giving different names to the same thing?
    March R; Schott C
    Per Med; 2017 Nov; 14(6):463-466. PubMed ID: 29749854
    [No Abstract]   [Full Text] [Related]  

  • 12. Epistemology, Ethics, and Progress in Precision Medicine.
    Hey SP; Barsanti-Innes B
    Perspect Biol Med; 2016; 59(3):293-310. PubMed ID: 28479573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Medicine and Personalized Medicine in Cardiovascular Disease.
    Currie G; Delles C
    Adv Exp Med Biol; 2018; 1065():589-605. PubMed ID: 30051409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 15. Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic.
    Prudkin L; Nuciforo P
    Cell Oncol (Dordr); 2015 Feb; 38(1):39-48. PubMed ID: 25185990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards precision medicine for sepsis patients.
    Pickkers P; Kox M
    Crit Care; 2017 Jan; 21(1):11. PubMed ID: 28077168
    [No Abstract]   [Full Text] [Related]  

  • 17. Biomarkers for personalized medicine in GI cancers.
    Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landscape of granted US patents in personalized diagnostics for oncology from 2014 to 2018.
    Ouellette SB
    Expert Opin Ther Pat; 2019 Mar; 29(3):191-198. PubMed ID: 30712415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine and the Changing Landscape of Research Ethics.
    Hammer MJ
    Oncol Nurs Forum; 2016 Mar; 43(2):149-50. PubMed ID: 26906126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical pitfalls of personalized medicine.
    Senn S
    Nature; 2018 Nov; 563(7733):619-621. PubMed ID: 30482931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.